SCHEMBL2622281

SCHEMBL2622281

C=Cc1c(OC)c(OC)cc2c(OC)c(-c3c(C)cc4c(C=C)c(OC)c(OC)cc4c3OC)c(C)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 4/20 0.38
ACHE P22303 1/20 0.37
CYP19A1 P11511 2/20 0.36
NQO2 P16083 2/20 0.36
TUBB1 Q9H4B7 9/20 0.36
TUBB4A P04350 7/20 0.36
TUBB P07437 7/20 0.36
TUBA3C P0DPH7 7/20 0.36
TUBA1B P68363 7/20 0.36
TUBA4A P68366 7/20 0.36
TUBB4B P68371 7/20 0.36
TUBB3 Q13509 7/20 0.36
TUBB2A Q13885 7/20 0.36
TUBB8 Q3ZCM7 7/20 0.36
TUBA3E Q6PEY2 7/20 0.36
TUBA1A Q71U36 7/20 0.36
TUBA1C Q9BQE3 7/20 0.36
TUBB6 Q9BUF5 7/20 0.36
TUBB2B Q9BVA1 7/20 0.36
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13917719 0.88 AKR1B1 (0.40) AKR1B1TUBB1TUBB4ATUBBTUBA3C
SCHEMBL355474 0.84 AKR1B1 (0.50) AKR1B1ACHECYP19A1NQO2TUBB1
SCHEMBL2757192 0.79 AKR1B1 (0.46) AKR1B1ACHECYP19A1NQO2TUBB1
SCHEMBL2622282 0.75 PDE3B (0.43) AKR1B1ACHECYP19A1NQO2TUBB1
SCHEMBL353813 0.72 AKR1B1 (0.51) AKR1B1ACHECYP19A1NQO2TUBB1
SCHEMBL353909 0.70 MEN1 (0.43) AKR1B1CYP19A1NQO2CYP3A4MAPT
SCHEMBL12664485 0.70 AKR1B1 (0.43) AKR1B1CYP19A1NQO2CYP3A4MAPT
SCHEMBL12664482 0.69 RAD52 (0.42) ACHECYP19A1NQO2TUBB1TUBB4A
SCHEMBL353866 0.69 AKR1B1 (0.40) AKR1B1ACHECYP19A1NQO2
SCHEMBL4305857 0.68 ACHE (0.54) ACHECYP19A1NQO2TUBB1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163805-B2 Small molecule antagonists of Bcl-2 family proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2012-04-24 US disclosed
US-8163805-B2 Small molecule antagonists of Bcl-2 family proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2012-04-24 US disclosed
US-20100069344-A1 SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-03-18 US disclosed
US-20100069344-A1 SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-03-18 US disclosed
US-20090092684-A1 SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS GEORGETOWN UNIVERSITY 2009-04-09 US disclosed
US-20090092684-A1 SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS GEORGETOWN UNIVERSITY 2009-04-09 US disclosed
US-20090082424-A1 SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2009-03-26 US disclosed
US-7432304-B2 Small molecule antagonists of Bcl-2 family proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-10-07 US disclosed
US-7432304-B2 Small molecule antagonists of Bcl-2 family proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090092684-A1 SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS BCL2, BCL2L1, BCL2L2 AKR1B1 1880/4885ACHE 4874/4885CYP19A1 3676/4885
US-20100069344-A1 SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS BCL2L1, BCL2, BCL2L11 AKR1B1 1397/4885ACHE 4878/4885CYP19A1 3396/4885
US-20090082424-A1 SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS BCL2, BCL2L1, BCL2L2 AKR1B1 1880/4885ACHE 4874/4885CYP19A1 3676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.